ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sangamo strikes TxCell takeover to gain CAR-Treg pipeline
fiercebiotech
July 26, 2018Sangamo Therapeutics is set to acquire TxCell for its CAR-Treg platform and pipeline. The €72 million ($84 million) takeover will position Sangamo to move a CAR-carrying regulatory T cell candidate into testing in solid organ transplant patients next year
Pharma Sources Insight January 2025
